Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOSTEL III: nifedipine versus atosiban for threatened preterm labour
NL-OMON38113Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nifedipine and atosiban in Preterm labor (PTL) and preterm birth, sponsored by Amsterdam University Medical Center. Primary endpoint: Composite poor neonatal outcome. Started Jul 2011; status: active, not recruiting.
02
Drugs
nifedipineatosiban
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on NL-OMON38113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38113.